Community Health Systems, Inc (CYH) concluded trading on Thursday at a closing price of $4.29, with 7.03 million shares of worth about $30.17 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.88% during that period and on May 15, 2025 the price saw a gain of about 9.44%. Currently the company’s common shares owned by public are about 140.30M shares, out of which, 121.36M shares are available for trading.
Stock saw a price change of 26.55% in past 5 days and over the past one month there was a price change of 72.29%. Year-to-date (YTD), CYH shares are showing a performance of 43.48% which increased to 25.07% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.24 but also hit the highest price of $6.29 during that period. The average intraday trading volume for Community Health Systems, Inc shares is 3.10 million. The stock is currently trading 41.54% above its 20-day simple moving average (SMA20), while that difference is up 53.04% for SMA50 and it goes to 9.61% higher than SMA200.
Community Health Systems, Inc (NYSE: CYH) currently have 140.30M outstanding shares and institutions hold larger chunk of about 69.55% of that.
The stock has a current market capitalization of $601.91M and its 3Y-monthly beta is at 2.13. It has posted earnings per share of -$3.68 in the same period. It has Quick Ratio of 1.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CYH, volatility over the week remained 8.70% while standing at 7.71% over the month.
Stock’s fiscal year EPS is expected to rise by 69.16% while it is estimated to increase by 106.64% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on November 25, 2024 offering an Underweight rating for the stock and assigned a target price range of between $5 and $2.50 to it. On March 06, 2024, Barclays Initiated their recommendations, while on June 17, 2022, Loop Capital Initiated their ratings for the stock with a price target of $5. Stock get a Neutral rating from BofA Securities on June 15, 2022.
